Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

Dangerous Liaisons: Terrorism and Pharma

July 1, 2013

How vulnerable is Big Pharma to the predations of organized terrorist groups or that rogue malcontent with an agenda to wreak havoc on society?

Seeking Supply Chain Security

July 1, 2013

FDA wants pharma leaders to do more to ensure drug quality at home and abroad. Our Washington correspondent Jill Wechsler reports.

Innovation Calls Across the C-suite: Lessons From Wall Street

July 1, 2013

The lifeblood of the life sciences industry is continuous innovation—it is not a business that can survive by standing still.

Pharm Exec's 2013 Emerging Pharma Leaders

July 1, 2013

Meet the Emerging Pharma Leaders of 2013. These 15 trend setters represent the future of an industry that knows it must change: the question is how, and to what?

Wanted: A Trusted Advisor

June 18, 2013

Al Topin on redefining your ad agency's role in today's complex pharma market

Pharma Job Cuts Cause Anxiety in Europe

June 2, 2013

Is Europe doing enough to curb further job losses that could threaten the recovery of its economy?

When Gurus Get It Wrong

June 1, 2013

Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.

Washington Report: Innovation, Coverage, and Costs

June 1, 2013

The backlash against high prices for new medicines will impact research, patent exclusivity, and drug benefits.

From Locked Box to Data Sphere

June 1, 2013

Project Data Sphere aims to liberate clinical trial data sets from industry and academic vaults, in an attempt to catalyze cancer research and discovery.

ADVERTISEMENT

Click here